Revia
Formulated to support abstinence in recovery programs to target cravings for substances.
- Category
- Addiction Recovery
- Active ingredient
- Naltrexone
- Supply
- Rx
- Route
- Oral use
- Form
- Film-coated tablet
- Strengths
- 50mg
Revia details
- Conditions
- Alcohol Dependence · Opioid Dependence
- Alternative names
- Adepend
- Therapeutic class
- Opioid antagonist
- Pharmacological class
- Opioid antagonist
- Minor side effects
- nausea; dizziness; headache
- Moderate side effects
- insomnia; anxiety; abdominal pain
- Dosage forms
- Film-coated tablet
- Administration route
- Oral use
- Supply category
- Prescription only (specially controlled medicine)
- Manufacturer
- Bristol-Myers Squibb
- Onset Time
- 1 hour
- Duration
- 24 hours
- Storage instructions
- Store securely below 25°C; keep out of reach of children.
- Drug interactions
- opioid-containing analgesics; cough suppressants
- Age restrictions
- Not recommended for patients under 18 years.
Contraindications
acute hepatitis; liver failure; current opioid dependence; positive urine screen for opioids
Precautions and warnings
must be opioid-free before starting therapy; monitor liver function regularly; alert physicians if emergency opioid analgesia is required
Serious side effects
hepatotoxicity, requires immediate medical attention; depression, requires immediate medical attention
Patient summary
Formulated to support abstinence in recovery programs to target cravings for substances.
Mechanism of action
It acts as a competitive opioid receptor antagonist, effectively binding to brain opioid receptors to block the euphoric effects of opioids and alcohol.
Pregnancy and breastfeeding
Pregnancy: Only use if strictly necessary. Breastfeeding: Seek medical advice before use.
Where this medicine is registered
- Singapore
- Hong Kong
- Thailand
- Malaysia
- Philippines
- Indonesia
- Taiwan
- South Korea
- Japan
- Australia
- New Zealand
- UAE
- South Africa
About Revia
Revia contains the active ingredient naltrexone, which acts as an opioid antagonist to assist in the management of alcohol dependence and opioid dependence. Also sold as Adepend, this medication is manufactured by Bristol-Myers Squibb and supplied as a 50mg tablet.
Revia availability in Asia
Revia is registered across 13 markets, including South Korea, the UAE and Singapore, with availability also in Hong Kong, Thailand and Malaysia. While the original product remains an option, generic naltrexone produced in India offers a far more affordable alternative for patients seeking treatment consistency. For residents or those far from major healthcare centres, these options help maintain long-term support. As with any medication for complex substance dependency, Revia is best used under a doctor’s care.